(Q38140425)

English

The risk of fever following one dose of trivalent inactivated influenza vaccine in children aged ≥6 months to <36 months: a comparison of published and unpublished studies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 August 2017

The risk of fever following one dose of trivalent inactivated influenza vaccine in children aged ≥6 months to <36 months: a comparison of published and unpublished studies (English)

1 reference

Europe PubMed Central

29 August 2017

influenza vaccine

1 reference

based on heuristic

inferred from title

Stephen B. Lambert

4

1 reference

Europe PubMed Central

29 August 2017

Marlena C Kaczmarek

object named as

Marlena C Kaczmarek

1

0 references

object named as

Robert S Ware

3

0 references

5

object named as

Heath A Kelly

1 reference

Europe PubMed Central

29 August 2017

author name string

Uyen T Duong

2

1 reference

Europe PubMed Central

29 August 2017

language of work or name

0 references

publication date

19 September 2013

1 reference

Europe PubMed Central

29 August 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

29 August 2017

31

1 reference

Europe PubMed Central

29 August 2017

5359-5365

1 reference

Europe PubMed Central

29 August 2017

46

1 reference

Europe PubMed Central

29 August 2017

Influenza-Associated Deaths among Children in the United States, 2003–2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Safety and efficacy of trivalent inactivated influenza vaccine in young children: a summary for the new era of routine vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Epidemiological study of severe febrile reactions in young children in Western Australia caused by a 2010 trivalent inactivated influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Randomized controlled trial of dose response to influenza vaccine in children aged 6 to 23 months

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Safety and tolerability of a 2009 trivalent inactivated split-virion influenza vaccine in infants, children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Oil-in-water emulsion adjuvant with influenza vaccine in young children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Solicited adverse events after influenza immunization among infants, toddlers, and their household contacts.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

The immunogenicity and safety of a single 0.5 mL dose of virosomal subunit influenza vaccine administered to unprimed children aged ≥6 to <36 months: data from a randomized, Phase III study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6–35 months

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Safety and immunogenicity of a paediatric presentation of an influenza vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Long-term clinical trial safety experience with the inactivated split influenza vaccine, Vaxigrip

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Parental views on vaccine safety and future vaccinations of children who experienced an adverse event following routine or seasonal influenza vaccination in 2010.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Relationship between the population incidence of febrile convulsions in young children in Sydney, Australia and seasonal epidemics of influenza and respiratory syncytial virus, 2003-2010: a time series analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Fever following administration of two inactivated influenza vaccines--a survey of parents of New Zealand infants and children 5 years of age and under

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2013.09.005

7 January 2021

Identifiers

10.1016/J.VACCINE.2013.09.005

1 reference

Europe PubMed Central

29 August 2017

1 reference

Europe PubMed Central

29 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38140425&oldid=1873875385"